| Gene expression and in situ protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissue JA Aguiar, BJM Tremblay, MJ Mansfield, O Woody, B Lobb, A Banerjee, ... European Respiratory Journal 56 (3), 2020 | 179 | 2020 |
| COVID‐19 and pulmonary fibrosis: A potential role for lung epithelial cells and fibroblasts AE John, C Joseph, G Jenkins, AL Tatler Immunological reviews 302 (1), 228-240, 2021 | 160 | 2021 |
| Heterogeneity of tumour‐infiltrating lymphocytes in breast cancer and its prognostic significance M Althobiti, MA Aleskandarany, C Joseph, M Toss, N Mongan, ... Histopathology 73 (6), 887-896, 2018 | 82 | 2018 |
| Elevated MMP9 expression in breast cancer is a predictor of shorter patient survival C Joseph, M Alsaleem, N Orah, PL Narasimha, IM Miligy, S Kurozumi, ... Breast cancer research and treatment 182, 267-282, 2020 | 80 | 2020 |
| Kosakovsky Pond SL R Viana, S Moyo, DG Amoako, H Tegally, C Scheepers, CL Althaus, ... Kraemer MUG, Kuate-Lere L, Laguda-Akingba O, Lesetedi-Mafoko O, Lessells RJ …, 2022 | 77 | 2022 |
| Translational pharmacology of an inhaled small molecule αvβ6 integrin inhibitor for idiopathic pulmonary fibrosis AE John, RH Graves, KT Pun, G Vitulli, EJ Forty, PF Mercer, JL Morrell, ... Nature Communications 11 (1), 4659, 2020 | 74 | 2020 |
| Breast cancer intratumour heterogeneity: current status and clinical implications C Joseph, A Papadaki, M Althobiti, M Alsaleem, MA Aleskandarany, ... Histopathology 73 (5), 717-731, 2018 | 74 | 2018 |
| Overexpression of the cancer stem cell marker CD133 confers a poor prognosis in invasive breast cancer C Joseph, M Arshad, S Kurozomi, M Althobiti, IM Miligy, S Al-Izzi, MS Toss, ... Breast Cancer Research and Treatment 174, 387-399, 2019 | 61 | 2019 |
| The molecular mechanisms underlying reduced E-cadherin expression in invasive ductal carcinoma of the breast: high throughput analysis of large cohorts M Alsaleem, MS Toss, C Joseph, M Aleskandarany, S Kurozumi, ... Modern Pathology 32 (7), 967-976, 2019 | 45 | 2019 |
| Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity LT Bui, NI Winters, MI Chung, C Joseph, AJ Gutierrez, AC Habermann, ... Nature communications 12 (1), 4314, 2021 | 44 | 2021 |
| Molecular complexity of lymphovascular invasion: the role of cell migration in breast cancer as a prototype YA Kariri, MA Aleskandarany, C Joseph, S Kurozumi, OJ Mohammed, ... Pathobiology 87 (4), 218-231, 2020 | 36 | 2020 |
| Pathobiology of airway remodeling in asthma: the emerging role of integrins C Joseph, AL Tatler Journal of Asthma and Allergy, 595-610, 2022 | 35 | 2022 |
| The prognostic significance of interferon-stimulated gene 15 (ISG15) in invasive breast cancer YA Kariri, M Alsaleem, C Joseph, S Alsaeed, A Aljohani, S Shiino, ... Breast Cancer Research and Treatment 185, 293-305, 2021 | 34 | 2021 |
| The prognostic significance of immune microenvironment in breast ductal carcinoma in situ MS Toss, A Abidi, D Lesche, C Joseph, S Mahale, H Saunders, T Kader, ... British journal of cancer 122 (10), 1496-1506, 2020 | 34 | 2020 |
| A novel prognostic two-gene signature for triple negative breast cancer MA Alsaleem, G Ball, MS Toss, S Raafat, M Aleskandarany, C Joseph, ... Modern Pathology 33 (11), 2208-2220, 2020 | 33 | 2020 |
| A key genomic subtype associated with lymphovascular invasion in invasive breast cancer S Kurozumi, C Joseph, S Sonbul, S Alsaeed, Y Kariri, A Aljohani, S Raafat, ... British journal of cancer 120 (12), 1129-1136, 2019 | 32 | 2019 |
| The role of BUB and CDC proteins in low-grade breast cancers A Mukherjee, C Joseph, M Craze, E Chrysanthou, IO Ellis The Lancet 385, S72, 2015 | 32 | 2015 |
| The prognostic significance of ALDH1A1 expression in early invasive breast cancer M Althobiti, R El Ansari, M Aleskandarany, C Joseph, MS Toss, AR Green, ... Histopathology 77 (3), 437-448, 2020 | 31 | 2020 |
| Myxovirus resistance 1 (MX1) is an independent predictor of poor outcome in invasive breast cancer AI Aljohani, C Joseph, S Kurozumi, OJ Mohammed, IM Miligy, AR Green, ... Breast cancer research and treatment 181, 541-551, 2020 | 28 | 2020 |
| Phenotypic characterisation of breast cancer: the role of CDC42 E Chrysanthou, KL Gorringe, C Joseph, M Craze, CC Nolan, ... Breast cancer research and treatment 164, 317-325, 2017 | 26 | 2017 |
